title: [Not Available].
abstract: Pholcodine is an opioid that has been widely used worldwide since 1950 for the treatment of non-productive cough in children and adults. The results of early preclinical studies but also those of recent clinical trials have shown the antitussive efficacy of pholcodine to be superior to that of codeine, of longer duration, and with an equivalent or safer toxicity profile. Also, there is no risk of addiction. Concern had been raised over a possible cross-sensitisation with neuromuscular blocking agents. While a recent assessment of the available data by the European Medicines Agency (EMA) has confirmed the favourable risk-benefit ratio of pholcodine, further studies are needed to clear this point.
authors.affiliation: Service des Maladies Respiratoires, Hôpital Haut Lévêque, Pessac, France. Electronic address: elodieblfr@yahoo.fr.
authors.forename: Elodie
authors.initials: E
authors.lastname: Blanchard
authors.affiliation: Service des Maladies Respiratoires, Hôpital Haut Lévêque, Pessac, France.
authors.forename: Manuel Tunon
authors.initials: MT
authors.lastname: de Lara
keywords: cough; curare; efficacité; efficacy; neuromuscular blocking agents; pholcodine; tolerance; tolérance; toux